Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Net income (loss) from continuing operations	$ 1,571,000	$ (390,000)
Adjustments to reconcile net income from operations to net cash flows from operating activities:
Depreciation expense	1,000
Accretion income on notes receivable	(327,000)
Stock compensation expense	58,000
Paid in kind interest on subordinated note receivable	(337,000)
Gain on extinguishment of subordinated note receivable	(448,000)
Changes in assets and liabilities:
Prepaid expenses, income tax receivables, and other current assets	(696,000)
Deferred tax assets and other assets	(509,000)
Accounts payable	29,000
Accrued salaries and other accrued expenses	34,000
Other long-term liabilities	(280,000)
Net cash used by continuing operations	(904,000)	(390,000)
Cash flows from investing activities:
Purchase of property, plant and equipment	(10,000)
New borrowings on subordinated secured notes receivable	(29,000)
Net cash used by investing activities	(39,000)
Cash flows from financing activities:
Repurchase and retirement of common stock	(133,000)
Stock purchase and retirement for tax withholdings on vesting of restricted award	(30,000)
Net cash used by financing activities	(163,000)
Cash flows from discontinued operations:
Cash used by discontinued operations	(3,501,000)	(2,606,000)
Cash provided by investing activities	9,228,000	34,000
Cash provided (used) by financing activities	1,209,000	(619,000)
Net cash provided (used) by discontinued operations	6,936,000	(3,191,000)
Net increase in cash and restricted cash	5,830,000	(3,581,000)
Cash and restricted cash at beginning of period	631,000	4,212,000
Cash and restricted cash at end of period	6,461,000	631,000
Supplemental Non-Cash Disclosures:
Payments made on line of credit from proceeds of the sale	(1,348,000)
Principal reduction on subordinated secured promissory note	$ 60